Literature DB >> 23899917

Effect of socioeconomic status on inpatient mortality and use of postacute care after subarachnoid hemorrhage.

Blessing N R Jaja1, Gustavo Saposnik, Rosane Nisenbaum, Tom A Schweizer, Deven Reddy, Kelvin E Thorpe, R Loch Macdonald.   

Abstract

BACKGROUND AND
PURPOSE: Studies in the United States and Canada have demonstrated socioeconomic gradients in outcomes of acute life-threatening cardiovascular and cerebrovascular diseases. The extent to which these findings are applicable to subarachnoid hemorrhage is uncertain. This study investigated socioeconomic status-related differences in risk of inpatient mortality and use of institutional postacute care after subarachnoid hemorrhage in the United States and Canada.
METHODS: Subarachnoid hemorrhage patient records in the US Nationwide Inpatient Sample database (2005-2010) and the Canadian Discharge Abstract Database (2004-2010) were analyzed separately, and summative results were compared. Both databases are nationally representative and contain relevant sociodemographic, diagnostic, procedural, and administrative information. We determined socioeconomic status on the basis of estimated median household income of residents for patient's ZIP or postal code. Multinomial logistic regression models were fitted with adjustment for relevant confounding covariates.
RESULTS: The cohort consisted of 31,631 US patients and 16,531 Canadian patients. Mean age (58 years) and crude inpatient mortality rates (22%) were similar in both countries. A significant income-mortality association was observed among US patients (odds ratio, 0.77; 95% CI, 0.65-0.93), which was absent among Canadian patients (odds ratio, 0.97; 95% CI, 0.85-1.12). Neighborhood income status was not significantly associated with use of postacute care in the 2 countries.
CONCLUSIONS: Socioeconomic status is associated with subarachnoid hemorrhage inpatient mortality risk in the United States, but not in Canada, although it does not influence the pattern of use of institutional care among survivors in both countries.

Entities:  

Keywords:  Canada; United States; healthcare disparities; socioeconomic status; subarachnoid hemorrhage

Mesh:

Year:  2013        PMID: 23899917     DOI: 10.1161/STROKEAHA.113.001368

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  6 in total

1.  Changes in stroke mortality trends and premature mortality due to stroke in Serbia, 1992-2013.

Authors:  Zana Dolicanin; Dragan Bogdanovic; Konstansa Lazarevic
Journal:  Int J Public Health       Date:  2015-11-05       Impact factor: 3.380

2.  Outcomes after acute ischemic stroke in the United States: does residential ZIP code matter?

Authors:  Shikhar Agarwal; Venu Menon; Wael A Jaber
Journal:  J Am Heart Assoc       Date:  2015-03-15       Impact factor: 5.501

3.  Long-Term Effect of Income Level on Mortality after Stroke: A Nationwide Cohort Study in South Korea.

Authors:  Seungmin Jeong; Sung-Il Cho; So Yeon Kong
Journal:  Int J Environ Res Public Health       Date:  2020-11-11       Impact factor: 3.390

Review 4.  Determining rural risk for aneurysmal subarachnoid hemorrhages: A structural equation modeling approach.

Authors:  Linda Jayne Nichols; Seana Gall; Christine Stirling
Journal:  J Neurosci Rural Pract       Date:  2016 Oct-Dec

5.  Neurosurgeon academic impact is associated with clinical outcomes after clipping of ruptured intracranial aneurysms.

Authors:  Naif M Alotaibi; George M Ibrahim; Justin Wang; Daipayan Guha; Muhammad Mamdani; Tom A Schweizer; R Loch Macdonald
Journal:  PLoS One       Date:  2017-07-20       Impact factor: 3.240

6.  Sex and Economic Disparity Related to Reperfusion Therapies for Patients with Acute Ischemic Stroke in South Korea across a 10-Year Period: A Nationwide Population-Based Study Using the National Health Insurance Database.

Authors:  Jusun Moon; Jinyoung Shin; Jeehye Lee; Ho Jin Jeong; Hyeongsu Kim; Jaehyeong An; Sung Hyun Jo; Kwang-Pil Ko; Jeoungbin Choi
Journal:  Int J Environ Res Public Health       Date:  2022-03-05       Impact factor: 3.390

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.